We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

63 hedge funds and large institutions have $144M invested in Five Prime Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 62 → 63 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less capital invested

Capital invested by funds: $177M → $144M (-$33.7M)

Holders
63
Holders Change
+1
Holders Change %
+1.61%
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
20
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.21M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$3.16M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.06M
4
BI
BVF Inc
California
+$2.64M
5
Millennium Management
Millennium Management
New York
+$1.2M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$6.82M
2
BIT
BlackRock Institutional Trust
California
-$1.09M
3
GPCM
Granite Point Capital Management
Massachusetts
-$622K
4
Allianz Asset Management
Allianz Asset Management
Germany
-$550K
5
Goldman Sachs
Goldman Sachs
New York
-$409K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$25.2M +$3.06M +242,434 +13%
BI
2
BVF Inc
California
$17.1M +$2.64M +208,900 +17%
O
3
OrbiMed
New York
$12.6M – – –
TGHSA
4
TPG Group Holdings (SBS) Advisors
Texas
$12.4M – – –
EAM
5
Eventide Asset Management
Massachusetts
$9.07M – – –
QF
6
QVT Financial
New York
$7.57M – – –
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$5.87M +$5.21M +412,597 +472%
Goldman Sachs
8
Goldman Sachs
New York
$5.56M -$409K -32,417 -6%
PI
9
Putnam Investments
Massachusetts
$5.21M – – –
BFA
10
BlackRock Fund Advisors
California
$4.84M -$136K -10,816 -3%
Vanguard Group
11
Vanguard Group
Pennsylvania
$3.59M +$731K +57,930 +23%
AWMDMG
12
Austin W. Marxe & David M. Greenhouse
New York
$3.52M – – –
SAM
13
Senzar Asset Management
New York
$3.5M +$458K +36,300 +14%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$2.94M +$3.16M +250,815 New
Millennium Management
15
Millennium Management
New York
$2.38M +$1.2M +94,734 +88%
State Street
16
State Street
Massachusetts
$2.22M +$210K +16,650 +10%
Northern Trust
17
Northern Trust
Illinois
$1.96M +$995K +78,896 +89%
BIT
18
BlackRock Institutional Trust
California
$1.91M -$1.09M -86,090 -35%
Wells Fargo
19
Wells Fargo
California
$1.82M +$38.8K +3,079 +2%
PA
20
Perceptive Advisors
New York
$1.76M – – –
RSCM
21
Rock Springs Capital Management
Maryland
$1.35M -$126K -10,000 -8%
MSA
22
Mason Street Advisors
Wisconsin
$1.26M +$142K +11,250 +12%
WMSA
23
Weiss Multi-Strategy Advisers
New York
$1.06M +$189K +15,000 +20%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$796K -$22K -1,741 -3%
TCIM
25
TIAA CREF Investment Management
New York
$743K -$17K -1,348 -2%
1
2 3

FPRX Hedge Fund Activity: Q3 2014 in Review

63 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q3 2014, worth a combined $144M — down 19% from $177M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new FPRX positions and 8 closed out — a net gain of 1 holder — while 20 added to existing stakes and 17 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $5.21M. The largest seller was Franklin Resources, exiting entirely with an estimated $6.82M sold.

  • 63 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q3 2014, up from 62 in Q2 2014.
  • Funds reported $144M of Five Prime Therapeutics, Inc. stock for Q3 2014, down 19% quarter-over-quarter.
  • 9 funds opened new Five Prime Therapeutics, Inc. positions in Q3 2014 and 8 closed out, a net change of +1 holder.
  • The largest Five Prime Therapeutics, Inc. buyer in Q3 2014 was Adage Capital Partners, an estimated $5.21M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q3 2014 was Franklin Resources, an estimated $6.82M sold.

Based on aggregated 13F filings for Q3 2014.